MaPGAS Decision Making

Enrolling by invitation · Not applicable

Conditions studied: Gender Dysphoria, Gender Dysphoria, Adult, Gender Incongruence, Transgenderism, Transsexualism, Transgender Persons, Phalloplasty

In brief

The goal of this clinical trial is to test a new online tool designed to provide clear and understandable information to help individuals considering Metoidioplasty and Phalloplasty Gender Affirming Surgery (MaPGAS)make informed decisions The main questions it aims to answer are: * How user-friendly is the decision aid for individuals considering metoidioplasty and phalloplasty? * Does using the decision aid reduce uncertainty and improve readiness for making surgery decisions compared to usual care? Participants in this study will: * Be randomly assigned to either 1) receive usual care or 2) test the web-based decision aid. * Share their feedback on the tool's usability and its helpfulness in supporting decision-making. * Complete surveys before and after using the decision aid to measure any changes in their decision-making process. Researchers will compare participants who used the decision aid with those who received standard care to see if the decision aid reduces decisional uncertainty and improves readiness for surgery.

Key facts

Study ID

NCT06565663

Run by

Dartmouth-Hitchcock Medical Center

People needed

140

Starts

2024-10-23

Expected to finish

2028-03-06

Last updated by the study team

2026-03-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Assigned female on the original birth certificate.
• Self-identifies as transgender male and/or gender non-binary.
• Able to speak, read, and understand English at a sixth-grade level.
• Aged 18 or older.
• Resides in the USA.
• For decision aid refinement: Considering metoidioplasty or phalloplasty, or is post-operative.
• For intervention and control arm: Has a consultation scheduled for metoidioplasty or phalloplasty.

You may not qualify if…

• Participants involved in the initial tool refinement focus groups cannot participate in the intervention or control group to avoid contamination of the study outcomes.

Where it is running

• Dartmouth College — Hanover, New Hampshire, United States
• University of Utah — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.